<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR23">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nooka</surname>
    <given-names>AK</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients</article-title>
  <source>Leukemia</source>
  <year>2014</year>
  <volume>28</volume>
  <issue>3</issue>
  <fpage>690</fpage>
  <lpage>693</lpage>
  <pub-id pub-id-type="doi">10.1038/leu.2013.335</pub-id>
  <?supplied-pmid 24220275?>
  <pub-id pub-id-type="pmid">24220275</pub-id>
 </element-citation>
</ref>
